Stack Capital Group Inc. Announces Election of Directors
Get Alerts STCK Hot Sheet
Join SI Premium – FREE
TORONTO, June 20, 2024 (GLOBE NEWSWIRE) -- Stack Capital Group Inc., (“Stack Capital”) (TSX: STCK) is pleased to announce that at its annual meeting of shareholders, held virtually today, the four director nominees listed in Stack Capital’s management proxy circular dated May 13, 2024 (the “Circular”) were elected as directors of Stack Capital. Directors have been elected to serve until the close of the next annual meeting of shareholders.
The detailed results of the vote are as follows:
| Nominee | Votes For | % Votes For | Votes Against | % Votes Against |
| John K. Bell | 3,362,837 | 99.59% | 13,802 | 0.41% |
| Jeffrey Parks | 3,376,539 | 100.00% | 100 | 0.00% |
| Laurie Goldberg | 3,363,837 | 99.62% | 12,802 | 0.38% |
| Gerri Sinclair | 3,375,639 | 95.20% | 162,170 | 4.80% |
| * | The number of votes disclosed reflects shareholders voting at the meeting and proxies received by management in advance of the meeting. |
Stack Capital shareholders also approved the appointment of PricewaterhouseCoopers LLP as the auditor of Stack Capital for the ensuing year.
About Stack Capital
Stack Capital is an investment holding company and its business objective is to invest in equity, debt and/or other securities of growth-to-late-stage private businesses. Through Stack Capital, shareholders have the opportunity to gain exposure to a diversified private investment portfolio; participate in the private market; and have liquidity due to the listing of the Common Shares on the TSX. At the same time, the public structure also allows the Company to focus its efforts on maximizing long-term performance through a portfolio of high growth businesses, which are not widely available to most Canadian investors.
For more information, please visit our website at www.stackcapitalgroup.com or contact:
Brian Viveiros
VP, Corporate Development and Investor Relations
647.280.3307
[email protected]
Source: Stack Capital Group Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Major Shareholder Announcement
- EyePoint Completes Enrollment of Both Pivotal Phase 3 Trials of DURAVYU™ for Treatment of Diabetic Macular Edema (DME)
- CITIZENS FINANCIAL SERVICES, INC. REPORTS UNAUDITED SECOND QUARTER 2026 FINANCIAL RESULTS
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share